Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

5.4K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.4K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

728
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
728
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

6.8K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.8K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

955
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
955
Male Sexual Response: Erection & Ejaculation01:17

Male Sexual Response: Erection & Ejaculation

27.0K
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
27.0K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

552
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
552

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urine Glycosaminoglycan Scores for Surveillance of Recurrence in Intermediate- and High-risk Nonmetastatic Clear Cell Renal Cell Carcinoma-An Observational Prospective Multicentre Diagnostic Test Cohort Study.

European urology oncology·2025
Same author

Targeted augmented reality-guided transperineal prostate biopsies study: initial experience.

Therapeutic advances in urology·2024
Same author

Sublingual MV140 for Prevention of Recurrent Urinary Tract Infections.

NEJM evidence·2024
Same author

A practical guide on the non-antibiotic options available in the prevention of recurrent urinary tract infections in women.

Urologia·2023
Same author

Effect of Robot-Assisted Radical Cystectomy With Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients With Bladder Cancer: A Randomized Clinical Trial.

JAMA·2022
Same author

Case of the month from the Department of Urology, Oxford University Hospitals, Oxford, UK: open partial nephrectomy of a transplant kidney in a patient with Fabry's disease.

BJU international·2022
Same journal

Mast Cells and Cardiovascular Disorders.

Current vascular pharmacology·2026
Same journal

Occupational and Environment-Related Cardiovascular Disease: A Comprehensive Review of the Literature.

Current vascular pharmacology·2026
Same journal

Metalloproteinases 2 and 9 as Biomarkers in Acute Elevation of Blood Pressure.

Current vascular pharmacology·2026
Same journal

Is the Cardiovascular Risk Increased in Patients with Isolated Systolic Hypertension and Anemia?

Current vascular pharmacology·2026
Same journal

Periodontal Disease and Cardiovascular Risk Factors.

Current vascular pharmacology·2026
Same journal

The Use of Colchicine in Cardiovascular Disease: Anti-Inflammatory Mechanisms and Clinical Utility.

Current vascular pharmacology·2026
See all related articles

Related Experiment Video

Updated: Mar 29, 2026

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
07:46

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 15, 2010

44.6K

Is Erectile Dysfunction an Example of Abnormal Endothelial Function?

Christopher Blick1, Robert W Ritchie, Mark E Sullivan

  • 1Department of Urology, The Churchill hospital, Oxford. cblick@doctors.org.uk.

Current Vascular Pharmacology
|December 8, 2015
PubMed
Summary
This summary is machine-generated.

Erectile dysfunction (ED) is linked to vascular disease. Endothelial dysfunction, impacting nitric oxide (NO) pathways, is a key factor in ED and cardiovascular disease development.

More Related Videos

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test
06:35

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test

Published on: April 27, 2016

19.0K
Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
08:42

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research

Published on: October 22, 2014

28.1K

Related Experiment Videos

Last Updated: Mar 29, 2026

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
07:46

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 15, 2010

44.6K
Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test
06:35

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test

Published on: April 27, 2016

19.0K
Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
08:42

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research

Published on: October 22, 2014

28.1K

Area of Science:

  • Urology
  • Cardiology
  • Vascular Biology

Background:

  • Erectile dysfunction (ED) affects many middle-aged men and often signals underlying systemic vascular disease.
  • The pathophysiology of ED and cardiovascular disease (CVD) are interconnected, with endothelial dysfunction being an early commonality.
  • A healthy endothelium is crucial for regulating penile vascular tone via nitric oxide (NO) dependent and independent mechanisms.

Purpose of the Study:

  • To review the critical role of the endothelium in erectile dysfunction.
  • To analyze the pathways involved in endothelial dysfunction related to ED.
  • To identify current and potential therapeutic targets for ED stemming from endothelial dysfunction.

Main Methods:

  • Literature review of current research on endothelial function in ED and CVD.
  • Analysis of the molecular mechanisms underlying endothelial dysfunction, including NO bioavailability and phosphodiesterase activity.
  • Examination of NO-independent pathways contributing to ED.

Main Results:

  • Endothelial dysfunction disrupts the balance of vasoconstriction and vasodilation necessary for erectile function.
  • Reduced nitric oxide (NO) bioavailability and increased phosphodiesterase activity impair smooth muscle relaxation and erectile function.
  • Endothelium-derived NO-independent mediators also contribute to ED in cases of endothelial damage.

Conclusions:

  • The endothelium plays a pivotal role in maintaining erectile function.
  • Endothelial dysfunction is a significant contributor to ED and a marker for cardiovascular risk.
  • Understanding these pathways offers opportunities for novel therapeutic strategies for ED.